• 1
    UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. 2011.
  • 2
    Irwig L, McCaffery K, Salkeld G, Bossuyt P. Informed choice for screening: implications for evaluation. BMJ, 2006; 332: 11481150.
  • 3
    Hewitson P, Austoker J. Part 2: patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing. BJU International, 2005; 95 (Suppl. 3): 1632.
  • 4
    Philips Z, Avis M, Whynes DK. Knowledge of cervical cancer and screening among women in east-central England. International Journal of Gynecological Cancer, 2005; 15: 639645.
  • 5
    van Rijn AF, van Rossum LG, Deutekom M et al. Getting adequate information across to colorectal cancer screening subjects can be difficult. Journal of Medical Screening, 2008; 15: 149152.
  • 6
    Korfage IJ, van Ballegooijen BM, Wauben B, Habbema JD, Essink-Bot ML. Informed choice on Pap smear still limited by lack of knowledge on the meaning of false-positive or false-negative test results. Patient Education and Counseling, 2011; 85: 214218.
  • 7
    van den Bergh KA, Essink-Bot ML, van Klaveren RJ, de Koning HJ. Informed participation in a randomised controlled trial of computed tomography screening for lung cancer. European Respiratory Journal, 2009; 34: 711720.
  • 8
    Marteau TM, Dormandy E, Michie S. A measure of informed choice. Health Expectations, 2001; 4: 99108.
  • 9
    van Rossum LG, van Rijn AF, Laheij RJ et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology, 2008; 135: 8290.
  • 10
    Denters MJ, Deutekom M, Fockens P, Bossuyt PM, Dekker E. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands. BMC Gastroenterology, 2009; 9: 28.
  • 11
    Wald N. Information leaflets in medical screening. Journal of Medical Screening, 2006; 13: 109.
  • 12
    Schoonen HM, Essink-Bot ML, van Agt HM, Wildschut HI, Steegers EA, de Koning HJ. Informed decision-making about the fetal anomaly scan: what knowledge is relevant? Ultrasound in Obstetrics and Gynecology, 2011; 37: 649657.
  • 13
    Schoonen HM, van Agt HM, Essink-Bot ML, Wildschut HI, Steegers EA, de Koning HJ. Informed decision-making in prenatal screening for Down's syndrome: what knowledge is relevant? Patient Education and Counseling, 2011; 84: 265270.
  • 14
    Dormandy E, Tsui EY, Marteau TM. Development of a measure of informed choice suitable for use in low literacy populations. Patient Education and Counseling, 2007; 66: 278295.
  • 15
    Deutekom M, van Rijn AF, Dekker E et al. Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands. European Journal of Public Health, 2009; 19: 400402.
  • 16
    van Rijn AF, van Rossum LG, Deutekom M et al. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test. Journal of Public Health (Oxford), 2008b; 30: 461465.
  • 17
    Quick BW, Hester CM, Young KL, Greiner KA. Self-reported barriers to colorectal cancer screening in a racially diverse, low-income study population. Journal of Community Health, 2012; [Epub ahead of print].
  • 18
    Hol L, de Jonge V, van Leerdam ME et al. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy. European Journal of Cancer, 2010; 46: 059066.
  • 19
    Steckelberg A, Hulfenhaus C, Haastert B, Muhlhauser I. Effect of evidence based risk information on “informed choice” in colorectal cancer screening: randomised controlled trial. BMJ, 2011; 342: d3193.
  • 20
    Graser A, Stieber P, Nagel D et al. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut, 2009; 58: 241248.
  • 21
    Robb K, Wardle J, Stubbings S et al. Ethnic disparities in knowledge of cancer screening programmes in the UK. Journal of Medical Screening, 2010; 17: 125131.
  • 22
    Smith SK, Trevena L, Simpson JM, Barratt A, Nutbeam D, McCaffery KJ. A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial. BMJ, 2010; 341: c5370.
  • 23
    Mathieu E, Barratt A, Davey HM, McGeechan K, Howard K, Houssami N. Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. Archives of Internal Medicine, 2007; 167: 20392046.
  • 24
    Chan EC, McFall SL, Byrd TL et al. A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT. Patient Education and Counseling, 2011; 84: e44e51.